Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling
Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling
复制标题
染色体 14q31 缺失驱动的 ZC3H14 下调通过激活整合素信号传导促进肝细胞癌进展。
DOI:
10.1093/carcin/bgy146
复制
发表时间:
2019
期刊:
影响因子:
4.7
通讯作者:
Zhou Gangqiao
中科院分区:
文献类型:
--
作者:
Zhang Chuxiao;Cao Pengbo;Yang Aiqing;Xia Xia;Li Yuanfeng;Shi Mengting;Yang Ying;Wei Xiaojun;Yang Chun;Zhou Gangqiao
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Genomic copy number deletion at chromosome 14q31.1–32.13 was frequently observed in HCC; however, the relevant functional target(s) at that locus is not well determined. Here, we performed integrative genomic analyses and identifiedzinc finger CCCH-type containing 14 (ZC3H14)as a promising candidate at 14q31.1–32.13. We observed frequent copy number deletion (17.1%) and downregulation ofZC3H14in primary HCC tissues. Downregulation ofZC3H14was significantly associated with poor outcomes of patients with HCC. Overexpression of ZC3H14 in HCC cell lines significantly suppressed HCC cells growthin vitroand metastasisin vivo. In contrast, RNA interference silencing ofZC3H14inhibited its tumor-suppressive function. Mechanismly, through combing bioinformatics analyses and experimental investigation, we demonstrated that loss ofZC3H14promotes HCC progression through enhancing integrin pathway. This study suggests that ZC3H14 functions as a novel tumor suppressor and is a candidate prognostic biomarker for HCC patients.